The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study - Report - MDSpire
Advertisement
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study
Clinical Report: Thyroid Surgery in Italy During COVID-19 Pandemic - THYCOVIT Study
Overview
The THYCOVIT study analyzed the impact of the COVID-19 pandemic on thyroid surgery across 28 Italian endocrine surgical units. It found a significant reduction in surgical volume during the pandemic phases, with maintained care standards and no increase in aggressive tumor features despite delays.
Background
Italy was among the first European countries severely affected by COVID-19, leading to national lockdowns and healthcare system strain. Elective surgeries, including thyroidectomies, were postponed to allocate resources for COVID-19 patients and reduce infection risk. Thyroidectomy indications include malignancies, hyperthyroidism, and compressive goitre, with differentiated thyroid carcinoma being the most common neoplasm characterized by slow progression but potential for lymph node metastases. This study aimed to quantify surgical activity changes, assess care quality, and evaluate tumor aggressiveness during the pandemic.
Data Highlights
Phase
Period
COVID-19 New Cases
Mean Daily Cases
Deaths
Phase 1 (P1)
9 Mar–3 May 2020
201,953
3,671
28,344
Phase 2 (P2)
4 May–14 Jun 2020
27,323
650
5,591
Phase 3 (P3)
15 Jun–31 Aug 2020
31,567
404
1,176
Key Findings
Significant reduction in thyroid surgeries during COVID-19 phases compared to the same periods in 2019.
Surgical activity for thyroid malignancies was adequately maintained despite overall reductions.
Standards of care, including operative time, use of intraoperative nerve monitoring, and postoperative complication rates, were preserved during the pandemic.
No increase in aggressive tumor features such as lymph node metastases, extra-thyroidal extension, or tumor size was observed despite treatment delays.
Postoperative complications including hypoparathyroidism and recurrent laryngeal nerve injury rates remained consistent with pre-pandemic data.
Clinical Implications
Clinicians can be reassured that prioritizing thyroid malignancy surgeries during pandemic-related restrictions is feasible without compromising patient outcomes. Maintaining standard surgical protocols and monitoring can prevent increased postoperative complications. Careful patient selection and timing remain critical to avoid progression of thyroid neoplasms during healthcare disruptions.
Conclusion
The THYCOVIT study demonstrates that despite significant reductions in thyroid surgical volume during the COVID-19 pandemic in Italy, care quality and oncological outcomes were maintained. These findings support the resilience of endocrine surgical services under pandemic constraints.
References
Italian Ministry of Health 2020 -- COVID-19 Official Data
by Fabio Medas, Gian Luca Ansaldo, Nicola Avenia, Giancarlo Basili, Marco Boniardi, Marco Bononi, Aldo Bove, Paolo Carcoforo, Andrea Casaril, Giuseppe Cavallaro, Maria Grazia Chiofalo, Giovanni Conzo, Loredana De Pasquale, Paolo Del Rio, Gianlorenzo Dionigi, Chiara Dobrinja, Giovanni Docimo, Giuseppa Graceffa, Maurizio Iacobone, Nadia Innaro, Celestino Pio Lombardi, Nicola Palestini, Francesco Pedicini, Giuliano Perigli, Angela Pezzolla, Gregorio Scerrino, Stefano Spiezia, Mario Testini, Pietro Giorgio Calò
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
